Skip to main content

STERIS Value Stock - Dividend - Research Selection

STERIS

ISIN: IE00BFY8C754, WKN: A2PGLV

Market price date: 20.01.2022
Market price: 226,85 USD


STERIS Fundamental data and company key figures of the share

Annual reports in USD
Key figures 26-03-2021
Cash flow
Net operating cash flow 590.559.000
Capital Expenditures -214.516.000
Free cash flow 376.043.008
Balance sheet
Total Equity 3.393.880.000
Liabilities & Shareholders equity 5.425.580.000
Income statement
Net income 407.605.000
Eps (diluted) 4,760
Diluted shares outstanding 84.924.000
Net sales/revenue 3.030.900.000

Fundamental ratios calculated on: 20-01-2022

Ratios
Key figures 20-01-2022
Cash flow
P/C 32,62
   
P/FC 51,23
Balance sheet
ROI7,51
ROE62,55
Income statement
P/E47,66
Div. Yield0,64%
P/B5,68
P/S6,36


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
SymbolSTE
Market Capitalization19.265.009.664,00 USD
CountryUnited States
IndicesS&P 500,MSCI World Index
SectorsHealth Care Equipment
Raw Data SourceUS GAAP in Millionen USD
Stock Split1998-08-25,2.000000/1.000000; 1995-08-25,2.000000/1.000000
Internetwww.steris.com


Description of the company

STERIS plc provides infection prevention and other procedural products and services worldwide. It operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services. This segment offers its products and services to acute care hospitals, ambulatory surgery centers, and GI clinics. The Healthcare Specialty Services segment provides solutions and managed services, such as instrument and endoscope repair and maintenance solutions; custom process improvement consulting services; and outsourced instrument sterile processing services to acute care hospitals and other healthcare settings. The Life Sciences segment offers formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The company was founded in 1985 and is based in Dublin, Ireland.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov, www.steris.com


NEWS


Here's Why You Should Retain STERIS (STE) Stock for Now

2022-01-20
STERIS plc STE is well poised for growth in the coming months, backed by strong segmental performance. Further, the bullish fiscal 2022 outlook is encouraging. However, stiff competition and macroeconomic problems are concerning.

Key Financial Inc Buys WisdomTree U.S. LargeCap Dividend Fund, WisdomTree Global ex-U.S. ...

2022-01-19
Investment company Key Financial Inc (Current Portfolio) buys WisdomTree U.S. LargeCap Dividend Fund, WisdomTree Global ex-U.S.

Microsoft's $68.7 billion deal for Activision once again shows big tech's dominance over legacy media

2022-01-18
Microsoft takes big $68.7 billion swing on video game company Activision Blizzard while legacy media stays on sidelines

Fruth Investment Management Buys Steris PLC, Canadian Pacific Railway, Schwab U.S. ...

2022-01-14
Houston, TX, based Investment company Fruth Investment Management (Current Portfolio) buys Steris PLC, Canadian Pacific Railway, Schwab U.S.

Supreme Court vaccine mandate ruling won't bar companies from demanding Covid shots for workers — Biden vows to advocate for that

2022-01-13
President Biden urged companies to voluntarily impose Covid vaccination rules on workers after the Supreme Court blocked a government order to do that.

Two of Sen. Kyrsten Sinema's former aides have lobbied for corporate giants looking to influence Joe Biden's agenda

2022-01-11
Two of Sen. Kyrsten Sinema's former aides have become key aides for corporate giants looking to impact President Joe Biden's agenda.

Joe Manchin's former aides gain influential lobbying clients as their ex-boss battles Biden's agenda

2022-01-10
Former aides to Sen. Joe Manchin who are now lobbyists are scoring big clients as their ex-boss battles President Biden's agenda

Pixar's 'Turning Red' to skip theaters, head straight to Disney+ in March

2022-01-07
"Turning Red" is the third Pixar film to transition to Disney's streaming platform during the pandemic.

Microsoft, NVIDIA, and Dick's are some of today's stock picks for investors: Pro Market Movers Jan. 6

2022-01-06
Jim Cramer, Dan Ives of Wedbush Securities, Gene Munster of Loup, Aaron Kessler of Raymond James, Dan Niles of Satori Fund, Darrin Peller of Wolfe Research, Josh Brown of Ritholtz Wealth Management, Brenda Vingiello of Sand Hill Global Advisors, Sarat Sethi of DCLA, and Steve Weiss of Short Hills Capital explain why they are buying, selling, or holding specific stocks and ETFs

Watch CNBC's full interview with Sarat Sethi on his top stock picks for 2022

2022-01-06
Sarat Sethi, DCLA managing partner and portfolio manager, joins the 'Halftime Report' to discuss his top stock picks for 2022, which include Uber, Morgan Stanley, and Comcast.